Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma. [electronic resource]
Producer: 20170920Description: 379-389 p. digitalISSN:- 1432-0851
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bevacizumab -- administration & dosage
- Brain Neoplasms -- blood
- Chemoradiotherapy
- Cytokines -- blood
- Dacarbazine -- administration & dosage
- Disease-Free Survival
- Female
- Glioblastoma -- blood
- Humans
- Immunotherapy -- methods
- Leukocytes, Mononuclear -- drug effects
- Male
- Middle Aged
- T-Lymphocytes, Regulatory -- drug effects
- Temozolomide
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.